Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
The blockbuster model now delivers just 5% ROI: competitive pressures and falling R&D productivity will instigate a new pharmaceutical model that replaces the unsustainable blockbuster model - personalized medicine and the “nichebuster”.
Published By Business Insights
|
08 Feb 2005 |
$2875
|
Report
|
The absence of generic competition has meant that growth of branded generics has gone unchallenged. But by 2010, biologic medicines worth $11.2bn in sales annually are expected to lose patent protection in developed pharmaceutical markets.
Published By Business Insights
|
16 Mar 2005 |
$2875
|
Report
|
DNA microarrays have changed the study of genetics by enabling the screening of whole genomes within a single microarray. Recent developments offer real potential in many applications from point-of-care diagnostics to high throughput lab devices.
Published By Business Insights
|
16 Jun 2005 |
$2875
|
Report
|
Pharma companies operate in multi-project, multi-product environments. The challenge facing executives is to decide which projects - each may have a strong value proposition and be championed by different business units - should receive investment.
Published By Business Insights
|
23 Jun 2005 |
$2875
|
Report
|
Although Vioxx is the most severe safety scare to date, similar problems could occur again given the commercial availability of various products that have been linked to widespread severe reactions and the lack of sufficient regulatory controls.
Published By Business Insights
|
14 Jul 2005 |
$2875
|
Report
|
SuperGen/MGI Pharma's Dacogen and Celgene's Revlimid are in pre-registration for treatment of myelodysplastic syndrome (MDS). However, a significant proportion of the MDS population will be left underserved by pharmacotherapy.
Published By Datamonitor
|
18 Oct 2005 |
$1900
|
Report
|
This report provides comprehensive coverage of the major cardiovascular markets in the Eastern European region, and offers detailed analysis of market trends, epidemiology, current leading brands of treatment, product sales forecast and future market leaders over the period 2005–2010 in 12 regional markets, including Poland, Hungary, Lithuania, the Czech Rep, and Russia.
Published By Business Insights
|
03 Jan 2006 |
$2875
|
Report
|
This report provides comprehensive coverage of the major cardiovascular markets in the Latin American region, and offers detailed analysis of market trends, epidemiology, current leading brands of treatment, product sales forecast and future market leaders over the period 2005–2010 in 10 markets: Brazil, Mexico, Argentina, Puerto Rico, Chile, Venezuela, Colombia, Ecuador, Peru, Uruguay.
Published By Business Insights
|
06 Jan 2006 |
$2875
|
Report
|
This report provides comprehensive coverage of the major cardiovascular markets in the Asia Pacific region, and offers detailed analysis of market trends, epidemiology, current leading brands of treatment, product sales forecast and future market leaders over the period 2005–2010 in nine markets: China, India, Singapore, South Korea, Thailand, Philippines, Malaysia, Indonesia and Taiwan.
Published By Business Insights
|
12 Jan 2006 |
$2875
|
Report
|
Branding is a central issue in the pharma industry. But while the FMCG industry has highly sophisticated branding models, pharma is much less developed and product managers need to put brand equity at the heart of product development and marketing.
Published By Business Insights
|
25 Jan 2006 |
$2875
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.